Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-04-09
2009-08-04
Anderson, Rebecca L (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S390000
Reexamination Certificate
active
07569701
ABSTRACT:
Conventional I-form crystals of 5-hydroxy-1-methylhydantoin contain, remaining therein in a considerable amount, the organic solvent used in a purification step. In contrast, in II-form crystals, the amount of the organic solvent remaining therein is smaller than the detection limit. Namely, the II-form crystals contain substantially no residual organic solvent. The novel II-form crystals of 5-hydroxy-1-methylhydantoin obtained through recrystallization from water not only contain substantially no residual organic solvent, but also have a high bulk density and are hence advantageous for pharmaceutical preparation. They further have properties advantageous for production, such as low adhesion. The crystals are significantly useful as a material for medicines required to have high safety, such as drugs for renal insufficiency.
REFERENCES:
patent: 4281009 (1981-07-01), Konishi
patent: 4647574 (1987-03-01), Ienaga et al.
patent: 4935507 (1990-06-01), Takaya et al.
patent: 4985453 (1991-01-01), Ishii et al.
patent: 5084473 (1992-01-01), Mikami et al.
patent: 5120850 (1992-06-01), Bod et al.
patent: 5294615 (1994-03-01), Meyer et al.
patent: 5294636 (1994-03-01), Edwards et al.
patent: 5352694 (1994-10-01), Cuthbert
patent: 5412095 (1995-05-01), Morley et al.
patent: 5681843 (1997-10-01), Kotani et al.
patent: 6040326 (2000-03-01), Hotta et al.
patent: 6197806 (2001-03-01), Endou et al.
patent: 6251929 (2001-06-01), Naiki et al.
patent: 6451831 (2002-09-01), Ienaga et al.
patent: 57114578 (1982-07-01), None
patent: 60188373 (1985-09-01), None
patent: S61 043168 (1986-03-01), None
patent: 61122275 (1986-06-01), None
patent: S61 211567 (1986-09-01), None
patent: 62045525 (1987-02-01), None
patent: H01 299276 (1989-12-01), None
patent: 03-072463 (1991-03-01), None
patent: H04 342556 (1992-11-01), None
patent: H07 149732 (1995-06-01), None
patent: H08 269018 (1996-10-01), None
patent: 09-227377 (1997-09-01), None
patent: H10 072446 (1998-03-01), None
patent: H11 171843 (1999-06-01), None
patent: 2000-212083 (2000-08-01), None
patent: 2002-241283 (2002-08-01), None
patent: 2004-123735 (2004-04-01), None
patent: 2004-123736 (2004-04-01), None
Byrn, et al. ed. “Comparing X-ray Powder Data”. Solid State Chemistry of Drugs, 2ndedition, (1999) p. 63.
Byrn, et al. ed. “Comparing X-Ray Powder Data”. Solid State Chemistry of Drugs, 2ndedition, p. 63, (1999).
Ienaga et al.—Bioactive Compounds Produced in Animal Tissues (II); Two Hydantoin Plant Growth Regulators Isolated From Rabbit Skin Tissue,Tetrahedron Letters, vol. 28, No. 39, pp. 4587-4588, 1987.
Ienaga et al.—The Stepwise Mammalian Oxidation of the Hydantoin 1-Methylimidazolidine-2,4-dione into Methylimidazolidinetrione via 5-Hydroxy-1-methyl-imidazolidine-2,4-dione,J. Chem. Soc., Perkin Trans. 1, pp. 1153-1156, 1989.
Meanwell et al.—Diethyl 2,4-Dioxoimidazolidine-t-phosphonates: Homer-Wadsworth-Emmons Reagents for the Mild and Efficient Preparation of C-5 Unsaturated Hydantoin Derivatives,J. Org. Chem., vol. 56, No. 24, pp. 6897-6904, 1991.
U.S. Appl. No. 11/110,267, filed Apr. 20, 2005, Okamoto et al.
U.S. Appl. No. 11/110,111, filed Apr. 20, 2005, Okamoto et al.
Ishii Akira
Nishimura Naoharu
Okamoto Kaoru
Anderson Rebecca L
Greenblum & Bernstein P.L.C.
Nippon Zoki Pharmaceutical Co. Ltd.
Young Shawquia
LandOfFree
Crystal form of 5-hydroxy-1-methylimidazolidin-2,4-dione does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystal form of 5-hydroxy-1-methylimidazolidin-2,4-dione, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystal form of 5-hydroxy-1-methylimidazolidin-2,4-dione will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4093428